Transcranial Magnetic Stimulation in Parkinson's disease

Transcranial Magnetic Stimulation in Parkinson's disease - TMS Parkinson's

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022356

Enrollment

Registered

2020-07-16

Start date

2021-01-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PARKINSON G20

Interventions

Group 1: TMS real treatment Group 2: TMS sham treatment

Eligibility

Sex/Gender

All

Age

40 Years to 85 Years

Inclusion criteria

Inclusion criteria: Parkinson's disease

Exclusion criteria

Exclusion criteria: atypical Parkinson

Design outcomes

Primary

Measure	Time frame
WHAT improvement of posturale stability WHEN last day of Treatment HOW PosturoMed	—

Secondary

Measure	Time frame
improvement of UPDRS III	—

Countries

Germany

Contacts

Public ContactOliver Kaut

UKB

oliver.kaut@ukbonn.de022828714431

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026